InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Rafferty Emily Ann. Insider active across 1 company, notably Evolent Health, Inc.. Aggregated, 5 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €442k. History available since 15 August 2023. The latest transaction was filed on 1 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Rafferty Emily Ann is Chief Operating Officer at Evolent Health, Inc. Across 5 total filings, the 5 sampled filings run from 2023-08-17 to 2025-03-04 and show EUR 0 in purchases and EUR 442337 in sales, with the modal transaction nature listed as Retenue fiscale.